Tech Company Financing Transactions
Sangon Biotech Funding Round
Sangon Biotech, operating out of Shanghai, secured $290 million from Novo Holdings, CDB Technology Venture Capital and China Merchant Health.
Transaction Overview
Company Name
Announced On
8/17/2023
Transaction Type
Venture Equity
Amount
$290,000,000
Round
Undisclosed
Investors
Proceeds Purpose
We will help the China-based company diversify its portfolio and expand internationally.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
No. 698, Xiangmin Road Songjiang District
Shanghai, 201611
CN
Shanghai, 201611
CN
Phone
Undisclosed
Website
Email Address
Overview
Provider of life science research services intended to offer researchers products and services at affordable prices. The company provides life science research tools and services including molecular biology kits, biochemicals, synthetic genes and synthetic oligos and specializes in gene and oligo synthesis, DNA and NGS sequencing and protein and antibody services, enabling life science researchers to promote basic research and product transformation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Qisong Wang
Chief Executive Officer
Luojia Wang
Browse more venture capital transactions:
Prev: 8/16/2023: Mitra Chem venture capital transaction
Next: 8/17/2023: AK Masonry and Concrete venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs